Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis.

MLA

Ao, Junjie, et al. “Dual Effects of Targeting Neuropilin-1 in Lenvatinib-Resistant Hepatocellular Carcinoma: Inhibition of Tumor Growth and Angiogenesis.” American Journal of Physiology. Cell Physiology, vol. 327, no. 4, Oct. 2024, pp. C1150–61. EBSCOhost, https://doi.org/10.1152/ajpcell.00511.2024.

APA

Ao, J., Qiang, N., Kanzaki, H., Nakamura, M., Kakiuchi, R., Zhang, J., Kojima, R., Koroki, K., Inoue, M., Kanogawa, N., Nakagawa, R., Kondo, T., Ogasawara, S., Nakamoto, S., Muroyama, R., Kato, J., & Kato, N. (2024). Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis. American Journal of Physiology. Cell Physiology, 327(4), C1150–C1161. https://doi.org/10.1152/ajpcell.00511.2024

Chicago

Ao, Junjie, Na Qiang, Hiroaki Kanzaki, Masato Nakamura, Risa Kakiuchi, Jiaqi Zhang, Ryuta Kojima, et al. 2024. “Dual Effects of Targeting Neuropilin-1 in Lenvatinib-Resistant Hepatocellular Carcinoma: Inhibition of Tumor Growth and Angiogenesis.” American Journal of Physiology. Cell Physiology 327 (4): C1150–61. doi:10.1152/ajpcell.00511.2024.